KalVista Pharmaceuticals, Inc.

KALV · NASDAQ
Analyze with AI
4/30/2025
4/30/2024
4/30/2023
4/30/2022
Assets
Cash & Equivalents$98,644$31,789$56,238$30,732
Short-Term Investments$89,002$178,612$93,137$135,470
Receivables$15,141$10,871$18,644$16,807
Inventory$0$0$0$0
Other Curr. Assets$38,903$4,418$4,307$10,638
Total Curr. Assets$241,690$225,690$172,326$193,647
Property Plant & Equip (Net)$1,988$9,147$10,770$10,040
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$7,092$567$106$193
Total NC Assets$9,080$9,714$10,876$10,233
Other Assets$0$0$0$0
Total Assets$250,770$235,404$183,202$203,880
Liabilities
Payables$4,883$9,107$4,817$3,638
Short-Term Debt$1,977$1,302$1,087$977
Tax Payable$0$0$0$0
Deferred Revenue$11,000$0$0$0
Other Curr. Liab.$27,307$12,398$9,128$6,961
Total Curr. Liab.$45,167$22,807$15,032$11,576
LT Debt$4,330$6,015$7,145$7,211
Deferred Rev, NC$105,882$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$110,212$6,015$7,145$7,211
Other Liabilities$0$0$0$0
Cap. Leases$6,307$7,317$8,232$8,188
Total Liabilities$155,379$28,822$22,177$18,787
Equity
Pref Stock$0$0$0$0
Common Stock$50$42$34$25
Retained Earnings-$653,170-$469,726-$343,082-$250,175
AOCI-$5,214-$3,488-$3,060-$3,861
Other Equity$753,725$679,754$507,133$439,104
Total Equity$95,391$206,582$161,025$185,093
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$250,770$235,404$183,202$203,880
Net Debt-$92,337-$24,472-$48,006-$22,544
KalVista Pharmaceuticals, Inc. (KALV) Financial Statements & Key Stats | AlphaPilot